301 related articles for article (PubMed ID: 16858682)
61. Analysis of p53, p16(INK4a), pRb and Cyclin D1 expression and human papillomavirus in primary ovarian serous carcinomas.
Bilyk OO; Pande NT; Buchynska LG
Exp Oncol; 2011 Sep; 33(3):150-6. PubMed ID: 21956468
[TBL] [Abstract][Full Text] [Related]
62. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
[TBL] [Abstract][Full Text] [Related]
63. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma.
Peng CY; Chen TC; Hung SP; Chen MF; Yeh CT; Tsai SL; Chu CM; Liaw YF
Anticancer Res; 2002; 22(2B):1265-71. PubMed ID: 12168936
[TBL] [Abstract][Full Text] [Related]
64. FRAT1 overexpression leads to aberrant activation of beta-catenin/TCF pathway in esophageal squamous cell carcinoma.
Wang Y; Liu S; Zhu H; Zhang W; Zhang G; Zhou X; Zhou C; Quan L; Bai J; Xue L; Lu N; Xu N
Int J Cancer; 2008 Aug; 123(3):561-8. PubMed ID: 18498136
[TBL] [Abstract][Full Text] [Related]
65. Long-term cultured IL-2-dependent T cell lines demonstrate p16(INK4a) overexpression, normal pRb/p53, and upregulation of cyclins E or D2.
Siwicki JK; Hedberg Y; Nowak R; Lodén M; Zhao J; Landberg G; Roos G
Exp Gerontol; 2000 May; 35(3):375-88. PubMed ID: 10832057
[TBL] [Abstract][Full Text] [Related]
66. p21 is associated with cyclin D1, p16INK4a and pRb expression in resectable non-small cell lung cancer.
Vonlanthen S; Heighway J; Kappeler A; Altermatt HJ; Borner MM; Betticher DC
Int J Oncol; 2000 May; 16(5):951-7. PubMed ID: 10762631
[TBL] [Abstract][Full Text] [Related]
67. Molecular and immunohistochemical analysis of the prognostic value of cell-cycle regulators in urothelial neoplasms of the bladder.
Yurakh AO; Ramos D; Calabuig-Fariñas S; López-Guerrero JA; Rubio J; Solsona E; Romanenko AM; Vozianov AF; Pellin A; Llombart-Bosch A
Eur Urol; 2006 Sep; 50(3):506-15; discussion 515. PubMed ID: 16624482
[TBL] [Abstract][Full Text] [Related]
68. Identification of target genes of the p16INK4A-pRB-E2F pathway.
Vernell R; Helin K; Müller H
J Biol Chem; 2003 Nov; 278(46):46124-37. PubMed ID: 12923195
[TBL] [Abstract][Full Text] [Related]
69. S-phase lengthening induced by p16(INK4a) overexpression in malignant cells with wild-type pRb and p53.
Chien WW; Domenech C; Catallo R; Salles G; Ffrench M
Cell Cycle; 2010 Aug; 9(16):3286-96. PubMed ID: 20703084
[TBL] [Abstract][Full Text] [Related]
70. Multiple abnormalities of the p16INK4a-pRb regulatory pathway in cultured melanoma cells.
Rizos H; Darmanian AP; Indsto JO; Shannon JA; Kefford RF; Mann GJ
Melanoma Res; 1999 Feb; 9(1):10-9. PubMed ID: 10338330
[TBL] [Abstract][Full Text] [Related]
71. Loss of p16INK4a expression is associated with vascular endothelial growth factor expression in squamous cell carcinoma of the esophagus.
Takeuchi H; Ozawa S; Shih CH; Ando N; Kitagawa Y; Ueda M; Kitajima M
Int J Cancer; 2004 Apr; 109(4):483-90. PubMed ID: 14991568
[TBL] [Abstract][Full Text] [Related]
72. Expression of senescence-related genes in human corneal endothelial cells.
Song Z; Wang Y; Xie L; Zang X; Yin H
Mol Vis; 2008 Jan; 14():161-70. PubMed ID: 18334933
[TBL] [Abstract][Full Text] [Related]
73. Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation.
Damalas A; Kahan S; Shtutman M; Ben-Ze'ev A; Oren M
EMBO J; 2001 Sep; 20(17):4912-22. PubMed ID: 11532955
[TBL] [Abstract][Full Text] [Related]
74. Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumours.
Gugger M; Kappeler A; Vonlanthen S; Altermatt HJ; Ris HB; Lardinois D; Borner MM; Heighway J; Betticher DC
Lung Cancer; 2001; 33(2-3):229-39. PubMed ID: 11551418
[TBL] [Abstract][Full Text] [Related]
75. The tumor-suppressive functions of the human INK4A locus.
Voorhoeve PM; Agami R
Cancer Cell; 2003 Oct; 4(4):311-9. PubMed ID: 14585358
[TBL] [Abstract][Full Text] [Related]
76. Ratio of expression of p16INK4a to p14ARF correlates with the progression of non-small cell lung cancer.
Moriyama S; Nakashima Y; Yano M; Kaji M; Yamakawa Y; Toyama T; Yamashita H; Iwase H; Sasaki H; Saito Y; Kiriyama M; Kato J; Fujii Y
Jpn J Cancer Res; 2002 Jul; 93(7):783-8. PubMed ID: 12149144
[TBL] [Abstract][Full Text] [Related]
77. Involvement of INK4A gene products in the pathogenesis and development of human osteosarcoma.
Benassi MS; Molendini L; Gamberi G; Magagnoli G; Ragazzini P; Gobbi GA; Sangiorgi L; Pazzaglia L; Asp J; Brantsing C; Picci P
Cancer; 2001 Dec; 92(12):3062-7. PubMed ID: 11753985
[TBL] [Abstract][Full Text] [Related]
78. Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro.
Schrage YM; Lam S; Jochemsen AG; Cleton-Jansen AM; Taminiau AH; Hogendoorn PC; Bovée JV
J Cell Mol Med; 2009 Sep; 13(9A):2843-52. PubMed ID: 18624751
[TBL] [Abstract][Full Text] [Related]
79. Contribution of p16INK4a and p21CIP1 pathways to induction of premature senescence of human endothelial cells: permissive role of p53.
Chen J; Huang X; Halicka D; Brodsky S; Avram A; Eskander J; Bloomgarden NA; Darzynkiewicz Z; Goligorsky MS
Am J Physiol Heart Circ Physiol; 2006 Apr; 290(4):H1575-86. PubMed ID: 16243918
[TBL] [Abstract][Full Text] [Related]
80. Id-1 promotes proliferation of p53-deficient esophageal cancer cells.
Hui CM; Cheung PY; Ling MT; Tsao SW; Wang X; Wong YC; Cheung AL
Int J Cancer; 2006 Aug; 119(3):508-14. PubMed ID: 16506209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
